NICE has published updated guidance on Diagnosis & Management of COPD, with new recommendations on: incidental findings on chest X‑rays or CT scans prognosis inhaled therapies prophylactic antibiotics oxygen therapies managing pulmonary hypertension and cor pulmonale lung volume reduction procedures self-management and exacerbation plans.
The Secretary of State for Health & Social Care, Matt Hancock, has asked the Chief Pharmaceutical Officer, Keith Ridge, to lead a review of polypharmacy, looking at: addressing ‘problematic polypharmacy’ creating a more efficient handover between primary and secondary care, for example ensuring GPs have the data they need and feel able to challenge and change prescribing made Continue Reading »
Bayer have announced plans to permanently discontinue nifedipine immediate-release 5mg & 10mg capsules (Adalat) in 2019. There are no other nifedipine immediate-release products licensed in the UK. The NHS Specialist Pharmacy Service have published an updated memo with advice on alternatives to immediate-release nifepidine, as well as information about the temporary supply issues with several Bayer modified-release nifedipine products (Adalat Continue Reading »
Bricanyl Turbohaler is the ONLY terbutaline inhaler marketed in the UK. Astra Zeneca UK Ltd have notified the Department of Health and Social Care of a temporary shortage and interruption to supplies. Some stock may be available during December 2018, but the shortage is unlikely to be fully resolved until the end of January 2019. The NHS Specialist Continue Reading »